269 related articles for article (PubMed ID: 9663601)
21. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
23. Changing incidence of lobular carcinoma in situ of the breast.
Li CI; Anderson BO; Daling JR; Moe RE
Breast Cancer Res Treat; 2002 Oct; 75(3):259-68. PubMed ID: 12353815
[TBL] [Abstract][Full Text] [Related]
24. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Chuba PJ; Hamre MR; Yap J; Severson RK; Lucas D; Shamsa F; Aref A
J Clin Oncol; 2005 Aug; 23(24):5534-41. PubMed ID: 16110014
[TBL] [Abstract][Full Text] [Related]
25. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
McCann J; Treasure P; Duffy S
J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
[TBL] [Abstract][Full Text] [Related]
26. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.
Soerjomataram I; Louwman WJ; van der Sangen MJ; Roumen RM; Coebergh JW
Br J Cancer; 2006 Aug; 95(3):393-7. PubMed ID: 16804522
[TBL] [Abstract][Full Text] [Related]
28. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
29. Cancer statistics: Breast cancer in situ.
Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
[TBL] [Abstract][Full Text] [Related]
30. The association between oral contraceptive use and lobular and ductal breast cancer in young women.
Nyante SJ; Gammon MD; Malone KE; Daling JR; Brinton LA
Int J Cancer; 2008 Feb; 122(4):936-41. PubMed ID: 17957781
[TBL] [Abstract][Full Text] [Related]
31. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.
Rawal R; Lorenzo Bermejo J; Hemminki K
Br J Cancer; 2005 Jan; 92(1):162-6. PubMed ID: 15570309
[TBL] [Abstract][Full Text] [Related]
32. Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis.
Mahar AL; Kagedan DJ; Hallet J; Coburn NG
Breast; 2017 Jun; 33():34-37. PubMed ID: 28279886
[TBL] [Abstract][Full Text] [Related]
33. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
34. Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?
Hemminki K; Granström C
Breast Cancer Res; 2002; 4(4):R7. PubMed ID: 12100745
[TBL] [Abstract][Full Text] [Related]
35. Risk of contralateral breast cancer among women with carcinoma in situ of the breast.
Habel LA; Moe RE; Daling JR; Holte S; Rossing MA; Weiss NS
Ann Surg; 1997 Jan; 225(1):69-75. PubMed ID: 8998122
[TBL] [Abstract][Full Text] [Related]
36. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
Saltzstein SL
Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
[No Abstract] [Full Text] [Related]
37. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
Claus EB; Stowe M; Carter D; Holford T
Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
[TBL] [Abstract][Full Text] [Related]
38. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
[TBL] [Abstract][Full Text] [Related]
39. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
King TA; Pilewskie M; Muhsen S; Patil S; Mautner SK; Park A; Oskar S; Guerini-Rocco E; Boafo C; Gooch JC; De Brot M; Reis-Filho JS; Morrogh M; Andrade VP; Sakr RA; Morrow M
J Clin Oncol; 2015 Nov; 33(33):3945-52. PubMed ID: 26371145
[TBL] [Abstract][Full Text] [Related]
40. Second primary cancers in patients with lung carcinoma.
Levi F; Randimbison L; Te VC; La Vecchia C
Cancer; 1999 Jul; 86(1):186-90. PubMed ID: 10391579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
